ユーザーIDをお忘れですか? or パスワードをお忘れですか?

メニュー 戻る Clinical-Development

Clinical Trials Development & Operations

This comprehensive track covers the latest advances in clinical research and operations. Sessions cover approaches to modernising design and conduct of clinical trials in the EU and beyond, advancing adoption and use of Complex Innovative Clinical Trials globally, with a particular focus on a patient and caregivers centred approach to clinical research. It will provide updates on key developments on Clinical Trials operations, the implementation of the EU Clinical Trial Regulation (CTR) implementation, data submission and transparency.

Who is This Track Designed For?

Professionals involved and/or interested in Clinical Trials Development & Operations. Regulatory Authorities, Regulatory Policy and Regulatory Affairs professionals, ethics Committees and HTAs, patients and healthcare professionals representatives, and other stakeholders involved in clinical research.

DIA Europe 2023 - Searchable Programme

The online program is now available. Explore the rich content we offer across 10 thought leadership tracks. 

View Searchable Programme

Topic Leaders

Lucia D'Apote

Lucia D'Apote

Executive Director Global Regulatory and R&D Policy (ELMAC and JAPAC)

Amgen, United Kingdom

Derek Johnston

Derek Johnston

QA Director, Regulatory Intelligence Office

Labcorp Drug Development, United Kingdom

Thomas Schindler

Thomas Schindler

CT Transparency Team in EFPIA; Director Medical Writing

BioNTech, Germany

DIA Europe 2023 Highlights

It will provide updates on key developments on the GCP Renovation (ICH E6, ICH E8), Clinical Trial Regulation, the Clinical Trial Information System, data submission, transparency, navigating ethical approval, study design in the digital age, innovative clinical trial designs (umbrella and platform trials, patient centricity), digital tools in development and other hot topics. It should be a must-attend for optimising development programmes and identifying cost savings through efficiency and innovation.

Explore All Tracks